![Antiemetics / Abdominal pain / General practice / Syndromes / Ketones / Irritable bowel syndrome / Diarrhea / Ramosetron / 5-HT3 antagonist / Medicine / Health / Gastroenterology Antiemetics / Abdominal pain / General practice / Syndromes / Ketones / Irritable bowel syndrome / Diarrhea / Ramosetron / 5-HT3 antagonist / Medicine / Health / Gastroenterology](https://www.pdfsearch.io/img/a0b61fc4be7b17d588a7d68d10f59eae.jpg) Date: 2015-05-26 01:47:13Antiemetics Abdominal pain General practice Syndromes Ketones Irritable bowel syndrome Diarrhea Ramosetron 5-HT3 antagonist Medicine Health Gastroenterology | | Astellas Receives Approval for a Supplemental New Drug Application for Irribow®/Irribow® OD, a Treatment of Diarrhea-predominant Irritable Bowel Syndrome, in Japan Tokyo, May 26, Astellas Pharma Inc. (“AstellaAdd to Reading ListSource URL: www.astellas.comDownload Document from Source Website File Size: 73,81 KBShare Document on Facebook
|